Towada Products · New Delhi, India · Last updated:
Gefitinib is an EGFR tyrosine kinase inhibitor used for non-small cell lung cancer with activating EGFR mutations. Towada Products exports it from New Delhi, India, supplying Geftinat and Iressa in the 250mg strength to licensed buyers in Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa. Pricing is on enquiry.
Gefitinib is a first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. It blocks the signalling of EGFR, on which some non-small cell lung cancers depend, especially those carrying activating EGFR mutations.
It is approved for locally advanced or metastatic non-small cell lung cancer with activating EGFR mutations, in the United States specifically as first-line treatment of tumours with exon 19 deletions or the exon 21 L858R substitution, confirmed by a validated test. The originator brand is Iressa. Gefitinib is on the WHO Model List of Essential Medicines, and the products in our catalog are 250mg tablets.
Erlotinib, the other first-generation EGFR inhibitor, is also in our catalog. Because the indication depends on mutation testing, gefitinib is ordered mainly by lung cancer centres and by distributors serving them. The tablets are kept at room temperature and ship without a cold chain. Tell us the quantity and the destination country, and we will confirm availability of each brand.
Gefitinib is a prescription medicine, and whether it is suitable for a patient is a decision for the treating doctor. This page describes the medicine for trade buyers; it is not medical advice.
Every gefitinib product page on this site. "Listed for" is the use given in our catalog. Availability is confirmed when you enquire.
| Product | Composition | Listed for |
|---|---|---|
| Geftinat 250mg | Gefitinib (250mg) | Non-small cell lung cancer |
| Iressa 250mg | Gefitinib (250mg) | Non-small cell lung cancer |
Export markets we serve: Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa. See our export markets →
Tell us which documents your regulator or customs broker needs and we will confirm what applies to the product you are ordering.
Gefitinib is an EGFR tyrosine kinase inhibitor used for non-small cell lung cancer with activating EGFR mutations. It is a prescription medicine, and whether it is suitable for a patient is a decision for the treating doctor.
Our catalog has 2 gefitinib product pages in the 250mg strength, from 2 brands: Geftinat and Iressa. The table on this page links to each product page; availability is confirmed when you enquire.
We ship from New Delhi by international courier or air cargo to licensed buyers in Southeast Asia, the CIS region, the Middle East and select markets in Europe and Africa, and have country pages for the Philippines, Russia, Kazakhstan, Uzbekistan, Iraq, Saudi Arabia and Brazil. Whether gefitinib can be imported, and by whom, is decided by the destination country's medicines regulator, so tell us the country and we will confirm what is possible. Every country we cover is listed on our export markets page.
Each shipment travels with a commercial invoice, a packing list and a courier or air waybill. We provide a Certificate of Analysis (CoA) for the batch and, where it is available for the product and the destination country requires it, a Certificate of Pharmaceutical Product (CoPP). A certificate of origin can be arranged on request.
Use the enquiry form on this page, WhatsApp +91 99995 62955 or email H.S.Gandhi@towadaproducts.in. Tell us the brand, strength, quantity and destination country, and we will reply with availability and a formal quotation.
This page is general information for trade buyers. It is not medical advice. Import rules differ by country and change over time; confirm the current requirements with your national medicines regulator before ordering.
Tell us the brand, strength, quantity and destination country. Pricing is confirmed in a formal quote. Prefer WhatsApp? Message +91 99995 62955.
Plain answers to the questions importers ask before ordering medicines from India.
